Contact PD/PI: COOPER, DAN M Our driving aim is to tangibly benefit health through fundamental translational science discovery, implementation, and training. The UCI Institute for Clinical and Translational Science (ICTS) will enable a wide range of translational research conducted at our institution and in our region in an environment of exceptional quality, safety and efficiency. We will empower programs and talent unique to our Hub that will foster innovation and continuous improvement enriching the entire national network. We will create and track novel programs in each of the essential areas outlined by NCATS: 1) Workforce Development: Trainees (at both the K and NRSA levels) will harness strengths at UCI, including existing immersive training programs in areas such as systems biology that can shorten and improve the training experience. Community-university externships will provide wide-ranging experiential learning including ?health and the judicial system? and ?drug discovery in local start-ups.? Our clinical trainees will play an integral role in workforce development of all staff, such as our recently developed certification program for study coordinators. Particular talent at UCI in both the science and implementation of team science resulted in a Team Science Core Curriculum, which will be integrated into all ICTS training. 2) Collaboration and Engagement: The ICTS ecosystem is one in which our academic health center actively collaborates with regional partners: the freestanding Children?s Hospital of Orange County (CHOC), the local VA, and a growing community-based accountable care organization in our region. The ICTS will lead an institutional and regional effort to improve quality and efficiency, preparing us as a Hub poised to excel in multicenter clinical investigations. By engaging the successful clinical trial experience of our faculty, building on years of effective community outreach, our integration with community clinics, and advanced EHR cohort discovery tools, the clinical trials Accrual and Retention Core is designed to optimally recruit from the youngest of the young (premature babies) to the oldest of the old (90+), and from typically underrepresented groups in clinical research. 3) Integration: Child health research will be fostered through: collaborations with the AAP Pediatric Research in Office Settings network; a formal Research Strategic Plan with CHOC; and through an Optional Module with nineteen other CTSAs (Child Health Research Acceleration through Multisite Planning). 4) Methods and Processes: Our involvement with the consortium of the five UC CTSAs (BRAID?Biomedical Research Acceleration Integration and Development) has served as a testing ground of novel approaches for multisite research. BRAID-initiated Trust-and-Rely IRB and the UC-Research Exchange cohort discovery tool are being integrated into the NCATS ACT project. Building on UCI strengths in exercise medicine, the Terminology Harmonization in Exercise Medicine and Exercise Science (an Optional Module) will transform the use of exercise biomarkers in clinical research. In sum, translational research will thrive in this environment where ?everything is questioned and there is no status quo.? Project Summary/Abstract Page 129 Contact PD/PI: COOPER, DAN M

Public Health Relevance

The challenges of diminishing resources for support of health care discovery can only be addressed by aligning the research and clinical missions of academic health centers in unprecedented ways. Our CTSA Hub is poised to transform clinical research in our region with novel training in collaborative team science; support for early phase transformative research; and by catalyzing partnerships with community and industry. We will link the creative energy of investigators at our Hub with the national network of CTSAs. As a result, potential advances in health will be studied in an environment of exceptional safety and quality, and reach the public as rapidly as possible. Project Narrative Page 130

Agency
National Institute of Health (NIH)
Institute
National Center for Advancing Translational Sciences (NCATS)
Type
Linked Specialized Center Cooperative Agreement (UL1)
Project #
5UL1TR001414-04
Application #
9468454
Study Section
Special Emphasis Panel (ZTR1)
Program Officer
Merchant, Carol
Project Start
2015-08-15
Project End
2019-03-31
Budget Start
2018-04-01
Budget End
2019-03-31
Support Year
4
Fiscal Year
2018
Total Cost
Indirect Cost
Name
University of California Irvine
Department
Pediatrics
Type
Schools of Medicine
DUNS #
046705849
City
Irvine
State
CA
Country
United States
Zip Code
92617
Al-Obeidi, E; Al-Tahan, S; Surampalli, A et al. (2018) Genotype-phenotype study in patients with valosin-containing protein mutations associated with multisystem proteinopathy. Clin Genet 93:119-125
Sorkin, Dara H; Rook, Karen S; Campos, Belinda et al. (2018) Rationale and study protocol for Unidas por la Vida (United for Life): A dyadic weight-loss intervention for high-risk Latina mothers and their adult daughters. Contemp Clin Trials 69:10-20
Lee, J Scott; Roberts, Andrew; Juarez, Dennis et al. (2018) Statins enhance efficacy of venetoclax in blood cancers. Sci Transl Med 10:
Lee, Yu-Po; Farhan, Saifal-Deen; Pendi, Arif et al. (2018) Does Addition of Tobramycin Powder Reduce Infection Rates After Spine Surgery? Global Spine J 8:816-820
Delaplain, Patrick T; Zhang, Lishi; Nguyen, Danh V et al. (2018) Effect of pump type on outcomes in neonates with congenital diaphragmatic hernia requiring ECMO. Perfusion 33:71-79
Amber, Kyle T; Valdebran, Manuel; Lu, Yuxin et al. (2018) Localized pretibial bullous pemphigoid arising in a patient on pembrolizumab for metastatic melanoma. J Dtsch Dermatol Ges 16:196-198
Butler, Merlin G; Kimonis, Virginia; Dykens, Elisabeth et al. (2018) Prader-Willi syndrome and early-onset morbid obesity NIH rare disease consortium: A review of natural history study. Am J Med Genet A 176:368-375
Amber, Kyle T; Valdebran, Manuel; Lu, Yuxin et al. (2018) Lokalisiertes prätibiales bullöses Pemphigoid bei einer Patientin unter Pembrolizumab-Therapie wegen eines metastasierten Melanoms. J Dtsch Dermatol Ges 16:196-198
Makdisi, Joy; de Feraudy, Sebastien; Zachary, Christopher B (2018) Vulvar Lymphangioma Circumscriptum Treated With Fractional Ablative Erbium: Yttrium Aluminium Garnet Laser. Dermatol Surg 44:1149-1151
Saager, Rolf B; Baldado, Melissa L; Rowland, Rebecca A et al. (2018) Method using in vivo quantitative spectroscopy to guide design and optimization of low-cost, compact clinical imaging devices: emulation and evaluation of multispectral imaging systems. J Biomed Opt 23:1-12

Showing the most recent 10 out of 488 publications